Skip to content

Lab study, 2020

Can researchers create an animal model that shows depression linked to the menstrual cycle?

Researchers created a rat model showing depression-like behavior during the non-receptive phase of the cycle (like the luteal phase in women) and reverse it with fluoxetine, suggesting hormonal changes cause premenstrual depression.

Early or limited evidence Female rats with regular menstrual cycles

What they did

Researchers created a rat model using a swimming test. Rats with normal menstrual cycles were tested for depression-like behavior in different cycle phases. Some rats had their ovaries removed to test whether hormones cause the depression-like symptoms. These rats were then given hormones and tested again. Some model rats received fluoxetine, an antidepressant.

What they found

Depression-like behavior occurred in the non-receptive phase of the cycle (similar to the luteal phase) and disappeared in the receptive phase. When ovaries were removed, depression symptoms disappeared. When hormones were given back, depression symptoms returned. Fluoxetine reversed depression-like symptoms in model rats with normal cycles. Rats showed changes in estrogen, progesterone, and brain chemicals including allopregnanolone, serotonin, norepinephrine, and GABA. Changes in GABA A receptor 4 alpha subunit expression also occurred. Fluoxetine returned all these chemicals and receptors to normal levels.

What it means for you

This animal model shows that hormonal changes during the menstrual cycle cause depression-like behavior and that antidepressants can reverse it by normalizing brain chemistry. However, this was animal research, not a study of real women.

About the study

Original title
A forced swim-based rat model of premenstrual depression: effects of hormonal changes and drug intervention
Authors
Wei S, Geng X, Li Z et al.
Journal
Aging
Year
2020
Study design
Lab study
What was tested
Fluoxetine (antidepressant) and hormone priming
Open access
Yes
Original abstract

Premenstrual dysphoric disorder (PMDD), a form of premenstrual syndrome (PMS), is a severe health disturbance that affects a patient's emotions; it is caused by periodic psychological symptoms, and its pathogenesis remains unclear. As depression-like symptoms are found in a majority of clinical cases, a reliable animal model of premenstrual depression is indispensable to understand the pathogenesis. Herein, we describe a novel rat model of premenstrual depression, based on the forced swimming test, with a regular estrous cycle. The results showed that in the estrous cycle, the depression-like behavior of rats occurred in the non-receptive phase and disappeared in the receptive phase. Following ovariectomy, the depression-like symptoms disappeared and returned after a hormone priming regimen. Moreover, fluoxetine, an anti-depressant, could reverse the behavioral symptoms in these model rats with normal estrous cycle. Further, the model rats showed significant changes in the serum levels of estrogen and progesterone, hippocampal levels of allopregnanolone, 5-hydroxytryptamine, norepinephrine, and γ-aminobutyric acid (GABA), and in the expression of GABA A receptor 4α subunit, all of which were reversed to physiological levels by fluoxetine. Overall, we established a reliable and standardized rat model of premenstrual depression, which may facilitate the elucidation of PMS/PMDD pathogenesis and development of related therapies.

Reproduced under CC-BY.

Topics